Literature DB >> 7793208

Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: effects on inflammatory mediators.

K Mikawa1, K Nishina, N Maekawa, H Obara.   

Abstract

BACKGROUND: Superoxide dismutase (SOD) has been shown to attenuate hyperoxic lung injury. This effect is thought to be exhibited by scavenging superoxide released from neutrophils and other aerobic cells. The aim of the current study was to investigate the effect of pre-treatment with SOD on the chemical mediators in hyperoxic lung injury.
METHODS: Thirty male anesthetized rabbits were allocated to receive one of three treatments (n = 10 for each group): ventilated with 100% oxygen for 36 h with or without recombinant human SOD (rhSOD) treatment, and ventilated with air for 36 h without rhSOD. In the rhSOD-treated group, a single intravenous dose of rhSOD 10,000 U kg BW-1 was administered immediately after the start of exposure to 100% oxygen and thereafter infused at a rate of 340,000 U kg BW-1 day-1 for 36 h until the animals were sacrificed. The lungs of all rabbits were ventilated with 100% oxygen or air. Haemodynamics, PaO2, and lung mechanics were recorded during the ventilation period. After exposure to 100% oxygen, lung mechanics, cell fraction of bronchoalveolar lavage fluid (BALF), activated complements, cytokines, and arachidonic acid metabolite concentrations in BALF were measured and analyzed. The lung wet-to-dry (W/D) weight ratio and albumin concentrations in BALF were determined as indices of pulmonary oedema.
RESULTS: Exposure to the high concentration of oxygen for 36 h caused no significant changes in haemodynamics but decreased compliance and increased A-aDo2. In the rhSOD-treated group, the decrease in compliance was not observed. At the end of the 36 hr-exposure period, however, hyperoxia significantly increased the lung W/D weight ratio, influx of neutrophils into the lung, BALF concentrations of C3a, C5a, tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, IL-8, thromboxane B2, and albumin. Pre-treatment with rhSOD attenuated these increases. Exposure to 100% oxygen caused extensive morphologic lung damage (alveolar haemorrhage and hyaline membrane formation), which was lessened by rhSOD.
CONCLUSION: These results indicate that intravenous rhSOD prevented hyperoxic lung injury (decreases in PaO2 and compliance, increased pulmonary vascular permeability, histopathological damage) in rabbits. This prophylactic effect of rhSOD amy be due, in part, to decreased chemical mediators such as activated complements, cytokines, and arachidonic acid metabolites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793208     DOI: 10.1111/j.1399-6576.1995.tb04069.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation.

Authors:  A B Waxman; O Einarsson; T Seres; R G Knickelbein; J B Warshaw; R Johnston; R J Homer; J A Elias
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 2.  Macrophages and tissue injury: agents of defense or destruction?

Authors:  Debra L Laskin; Vasanthi R Sunil; Carol R Gardner; Jeffrey D Laskin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 3.  Acute respiratory distress syndrome.

Authors:  J J Lunn; M J Murray
Journal:  Yale J Biol Med       Date:  1998 Nov-Dec

4.  Intravenous superoxide dismutase as a protective agent to prevent impairment of lung function induced by high tidal volume ventilation.

Authors:  Nan-Chun Wu; Fan-Ting Liao; Hao-Min Cheng; Shih-Hsien Sung; Yu-Chun Yang; Jiun-Jr Wang
Journal:  BMC Pulm Med       Date:  2017-07-26       Impact factor: 3.317

5.  Targeting complement anaphylatoxin C5a receptor in hyperoxic lung injury in mice.

Authors:  Ying Xu; Zhe Tian; Peiyu Xie
Journal:  Mol Med Rep       Date:  2014-07-18       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.